Article Versions Notes

Ploeg MC, Munts C, Seddiqi T, ten Brink TJL, Breemhaar J, Moroni L, Prinzen FW, van Nieuwenhoven FA. Culturing of Cardiac Fibroblasts in Engineered Heart Matrix Reduces Myofibroblast Differentiation but Maintains Their Response to Cyclic Stretch and Transforming Growth Factor β1. Bioengineering. 2022; 9(10):551. https://doi.org/10.3390/bioengineering9100551

Ploeg, Meike C., Chantal Munts, Tayeba Seddiqi, Tim J. L. ten Brink, Jonathan Breemhaar, Lorenzo Moroni, Frits. W. Prinzen, and Frans. A. van Nieuwenhoven. 2022. "Culturing of Cardiac Fibroblasts in Engineered Heart Matrix Reduces Myofibroblast Differentiation but Maintains Their Response to Cyclic Stretch and Transforming Growth Factor β1" Bioengineering 9, no. 10: 551. https://doi.org/10.3390/bioengineering9100551

Ploeg, M. C., Munts, C., Seddiqi, T., ten Brink, T. J. L., Breemhaar, J., Moroni, L., Prinzen, F. W., & van Nieuwenhoven, F. A. (2022). Culturing of Cardiac Fibroblasts in Engineered Heart Matrix Reduces Myofibroblast Differentiation but Maintains Their Response to Cyclic Stretch and Transforming Growth Factor β1. Bioengineering, 9(10), 551. https://doi.org/10.3390/bioengineering9100551